The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI
Launched by HILLEROD HOSPITAL, DENMARK · Nov 20, 2009
Trial Information
Current as of July 25, 2025
Terminated
Keywords
ClinConnect Summary
Prior to birth the fetal heart has a connection between the two atrias of the heart. After labour this connection often closes. About 10-15 % these connections remains open. This phenomenon is called patent foramen ovale or PFO, and is in most cases unsymptomatic.
The prevalence of PFO in patients with crytogenic (without known causes) stroke is much higher (about 40%)than the general population (about 10%). This has led to the theory that the presence of PFO can lead to stroke, by the passage of emboli from the peripheral venous circulation through the PFO to the brain by right-to-left sh...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke or TIA within 30 days
- • Above 50 years of age
- Exclusion Criteria:
- • Deceases og the esophagus
- • Dementia
- • Allergy to aspirin
- • Risk of non-compliance
- • Lacking ability to give written or oral consent
- • Atrial Fibrillation
- • Neurological deficit lasting less than 6 hours
About Hillerod Hospital, Denmark
Hillerød Hospital, located in Denmark, is a leading healthcare institution dedicated to advancing medical science through innovative clinical research. As a prominent sponsor of clinical trials, the hospital is committed to improving patient outcomes and healthcare practices by rigorously evaluating new treatments and interventions. With a multidisciplinary team of experienced researchers and healthcare professionals, Hillerød Hospital fosters a collaborative environment that prioritizes patient safety, ethical standards, and scientific integrity. The institution plays a vital role in contributing to the global medical community by facilitating high-quality research across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hillerød, Region H, Denmark
Patients applied
Trial Officials
Christian S Hansen, dr.
Principal Investigator
Hillerød Hospital. dept. of cardiology and endocrinology
Niels Tønder, Dr.
Study Director
Hillerød Hospital. dept. of cardiology and endocrinology
Kasper K Iversen, Dr.
Study Director
Hillerød Hospital. dept. of cardiology and endocrinology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials